Aesthetics in breast conserving therapy. do objectively measured results match patients' evaluations?
Standard
Aesthetics in breast conserving therapy. do objectively measured results match patients' evaluations? / Heil, Joerg; Dahlkamp, Julia; Golatta, Michael; Rom, Joachim; Domschke, Christoph; Rauch, Geraldine; Cardoso, Maria Joao; Sohn, Christof.
in: ANN SURG ONCOL, Jahrgang 18, Nr. 1, 01.2011, S. 134-138.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Aesthetics in breast conserving therapy. do objectively measured results match patients' evaluations?
AU - Heil, Joerg
AU - Dahlkamp, Julia
AU - Golatta, Michael
AU - Rom, Joachim
AU - Domschke, Christoph
AU - Rauch, Geraldine
AU - Cardoso, Maria Joao
AU - Sohn, Christof
PY - 2011/1
Y1 - 2011/1
N2 - BACKGROUND: To analyze the relationship of objective and subjective evaluation tools of breast aesthetics, we compare the results of the BCCT.core (breast cancer conservative treatment.cosmetic results) software, a semiautomated objective symmetry evaluation tool, with those of the Aesthetic Status of the BCTOS (Breast Cancer Treatment Outcome Scale) patient questionnaire.MATERIALS AND METHODS: We included 128 patients with one-sided, primary breast cancer, treated conservatively in a prospective, exploratory study in order to assess the inter-rater reliability of the BCCT.core and the agreement between the BCCT.core and the BCTOS preoperatively, shortly and 1 year after surgery. Therefore, we use agreement rates, multiple (mk), and weighted (wk) kappa coefficients as statistical methods. Furthermore, we analyzed patient-, tumor-, and therapy-related variables as possible covariates to explain agreement.RESULTS: The inter-rater reliability for the semiautomated BCCT.core is very good with agreement rates up to 84% (mk = 0.80). The agreement rates of the BCCT.core and the BCTOS Aesthetic Status range between 35 and 44% subject to the different times of assessment (wk = 0.34 at best). Moreover, the patients judge their aesthetic outcome more positively than the software. None of the considered patient-, tumor-, and therapy-related covariates turned out to explain agreement.CONCLUSION: The BCCT.core is a reliable instrument that shows fair agreement with patient's perspective.
AB - BACKGROUND: To analyze the relationship of objective and subjective evaluation tools of breast aesthetics, we compare the results of the BCCT.core (breast cancer conservative treatment.cosmetic results) software, a semiautomated objective symmetry evaluation tool, with those of the Aesthetic Status of the BCTOS (Breast Cancer Treatment Outcome Scale) patient questionnaire.MATERIALS AND METHODS: We included 128 patients with one-sided, primary breast cancer, treated conservatively in a prospective, exploratory study in order to assess the inter-rater reliability of the BCCT.core and the agreement between the BCCT.core and the BCTOS preoperatively, shortly and 1 year after surgery. Therefore, we use agreement rates, multiple (mk), and weighted (wk) kappa coefficients as statistical methods. Furthermore, we analyzed patient-, tumor-, and therapy-related variables as possible covariates to explain agreement.RESULTS: The inter-rater reliability for the semiautomated BCCT.core is very good with agreement rates up to 84% (mk = 0.80). The agreement rates of the BCCT.core and the BCTOS Aesthetic Status range between 35 and 44% subject to the different times of assessment (wk = 0.34 at best). Moreover, the patients judge their aesthetic outcome more positively than the software. None of the considered patient-, tumor-, and therapy-related covariates turned out to explain agreement.CONCLUSION: The BCCT.core is a reliable instrument that shows fair agreement with patient's perspective.
KW - Adult
KW - Aged
KW - Breast Neoplasms
KW - Carcinoma, Ductal, Breast
KW - Carcinoma, Lobular
KW - Cohort Studies
KW - Esthetics
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Mastectomy
KW - Mastectomy, Segmental
KW - Middle Aged
KW - Observer Variation
KW - Patient Satisfaction
KW - Prognosis
KW - Prospective Studies
KW - Software
KW - Survival Rate
KW - Clinical Trial
KW - Comparative Study
KW - Journal Article
U2 - 10.1245/s10434-010-1252-4
DO - 10.1245/s10434-010-1252-4
M3 - SCORING: Journal article
C2 - 20697820
VL - 18
SP - 134
EP - 138
JO - ANN SURG ONCOL
JF - ANN SURG ONCOL
SN - 1068-9265
IS - 1
ER -